436 related articles for article (PubMed ID: 27179545)
1. Cardiac Outcomes in Survivors of Pediatric and Adult Cancers.
Nathan PC; Amir E; Abdel-Qadir H
Can J Cardiol; 2016 Jul; 32(7):871-80. PubMed ID: 27179545
[TBL] [Abstract][Full Text] [Related]
2. [Cardiovascular complications of cancers and anti-cancer therapy].
Vyskočil J; Petráková K; Jelínek P; Furdek M
Vnitr Lek; 2017; 63(3):200-209. PubMed ID: 28379023
[TBL] [Abstract][Full Text] [Related]
3. Educational paper: decreasing the burden of cardiovascular disease in childhood cancer survivors: an update for the pediatrician.
Dillenburg RF; Nathan P; Mertens L
Eur J Pediatr; 2013 Sep; 172(9):1149-60. PubMed ID: 23361962
[TBL] [Abstract][Full Text] [Related]
4. Exposure to anthracyclines during childhood causes cardiac injury.
Lipshultz SE
Semin Oncol; 2006 Jun; 33(3 Suppl 8):S8-14. PubMed ID: 16781284
[TBL] [Abstract][Full Text] [Related]
5. Echocardiography and Alternative Cardiac Imaging Strategies for Long-Term Cardiotoxicity Surveillance of Cancer Survivors Treated with Chemotherapy and/or Radiation Exposure.
Garg V; Vorobiof G
Curr Oncol Rep; 2016 Aug; 18(8):52. PubMed ID: 27461436
[TBL] [Abstract][Full Text] [Related]
6. Cardiovascular disease: cause of morbidity and mortality in adult survivors of childhood cancers.
Chen MH; Colan SD; Diller L
Circ Res; 2011 Mar; 108(5):619-28. PubMed ID: 21372293
[TBL] [Abstract][Full Text] [Related]
7. Cardio-oncology issues among pediatric cancer and stem cell transplant survivors.
Hochberg JC; Cairo MS; Friedman DM
Cardiol Rev; 2014; 22(6):268-74. PubMed ID: 24926805
[TBL] [Abstract][Full Text] [Related]
8. Novel approaches to the prediction, diagnosis and treatment of cardiac late effects in survivors of childhood cancer: a multi-centre observational study.
Skitch A; Mital S; Mertens L; Liu P; Kantor P; Grosse-Wortmann L; Manlhiot C; Greenberg M; Nathan PC
BMC Cancer; 2017 Aug; 17(1):519. PubMed ID: 28774277
[TBL] [Abstract][Full Text] [Related]
9. Cardio-oncology, the myth of Sisyphus, and cardiovascular disease in breast cancer survivors.
Mavrogeni SI; Sfendouraki E; Markousis-Mavrogenis G; Rigopoulos A; Noutsias M; Kolovou G; Angeli C; Tousoulis D
Heart Fail Rev; 2019 Nov; 24(6):977-987. PubMed ID: 31134427
[TBL] [Abstract][Full Text] [Related]
10. Cardiac complications in childhood cancer survivors treated with anthracyclines.
Franco VI; Lipshultz SE
Cardiol Young; 2015 Aug; 25 Suppl 2():107-16. PubMed ID: 26377717
[TBL] [Abstract][Full Text] [Related]
11. [Treatment-related cardiotoxicity in childhood cancer survivors: Risk factors and follow-up].
Fresneau B; Fayech C; Butel T; Haddy N; Valteau-Couanet D; Ou P
Rev Med Interne; 2017 Feb; 38(2):125-132. PubMed ID: 27639916
[TBL] [Abstract][Full Text] [Related]
12. Canadian Cardiovascular Society Guidelines for Evaluation and Management of Cardiovascular Complications of Cancer Therapy.
Virani SA; Dent S; Brezden-Masley C; Clarke B; Davis MK; Jassal DS; Johnson C; Lemieux J; Paterson I; Sebag IA; Simmons C; Sulpher J; Thain K; Thavendiranathan P; Wentzell JR; Wurtele N; Côté MA; Fine NM; Haddad H; Hayley BD; Hopkins S; Joy AA; Rayson D; Stadnick E; Straatman L
Can J Cardiol; 2016 Jul; 32(7):831-41. PubMed ID: 27343741
[TBL] [Abstract][Full Text] [Related]
13. Benefits of antihypertensive medications for anthracycline- and trastuzumab-induced cardiotoxicity in patients with breast cancer: Insights from recent clinical trials.
Rygiel K
Indian J Pharmacol; 2016; 48(5):490-497. PubMed ID: 27721532
[TBL] [Abstract][Full Text] [Related]
14. Cardiotoxicity of anticancer treatments: Epidemiology, detection, and management.
Curigliano G; Cardinale D; Dent S; Criscitiello C; Aseyev O; Lenihan D; Cipolla CM
CA Cancer J Clin; 2016 Jul; 66(4):309-25. PubMed ID: 26919165
[TBL] [Abstract][Full Text] [Related]
15. Cardiovascular disease in survivors of childhood cancer.
Bansal N; Amdani SM; Hutchins KK; Lipshultz SE
Curr Opin Pediatr; 2018 Oct; 30(5):628-638. PubMed ID: 30124579
[TBL] [Abstract][Full Text] [Related]
16. High risk of symptomatic cardiac events in childhood cancer survivors.
van der Pal HJ; van Dalen EC; van Delden E; van Dijk IW; Kok WE; Geskus RB; Sieswerda E; Oldenburger F; Koning CC; van Leeuwen FE; Caron HN; Kremer LC
J Clin Oncol; 2012 May; 30(13):1429-37. PubMed ID: 22473161
[TBL] [Abstract][Full Text] [Related]
17. Cardiovascular disease after Hodgkin lymphoma treatment: 40-year disease risk.
van Nimwegen FA; Schaapveld M; Janus CP; Krol AD; Petersen EJ; Raemaekers JM; Kok WE; Aleman BM; van Leeuwen FE
JAMA Intern Med; 2015 Jun; 175(6):1007-17. PubMed ID: 25915855
[TBL] [Abstract][Full Text] [Related]
18. Managing chemotherapy-related cardiotoxicity in survivors of childhood cancers.
Lipshultz SE; Diamond MB; Franco VI; Aggarwal S; Leger K; Santos MV; Sallan SE; Chow EJ
Paediatr Drugs; 2014 Oct; 16(5):373-89. PubMed ID: 25134924
[TBL] [Abstract][Full Text] [Related]
19. Cardio-oncology: a multidisciplinary approach for detection, prevention and management of cardiac dysfunction in cancer patients.
Tajiri K; Aonuma K; Sekine I
Jpn J Clin Oncol; 2017 Aug; 47(8):678-682. PubMed ID: 28505345
[TBL] [Abstract][Full Text] [Related]
20. Anthracycline-related cardiotoxicity in childhood cancer survivors.
Lipshultz SE; Karnik R; Sambatakos P; Franco VI; Ross SW; Miller TL
Curr Opin Cardiol; 2014 Jan; 29(1):103-12. PubMed ID: 24284979
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
